Objectives-To determine the prevalence of pain arising from the zygapophysial joint in patients with chronic low back pain and to determine-whether any clinical features could distinguish patients with and without such pain. Methods-Sixty three patients with chronic low back pain were studied prospectively. All patients underwent a detailed history and physical examination as well as a series of intra-articular zygapophysial joint injections of 0-5% bupivacaine starting at the symptomatic level to a maximum ofthree levels or until the pain was abolished. They also received injections of normal saline into paraspinal muscles to act as controls. 
(Ann Rheum Dis 1995; 54: 100-106)
There has been considerable debate as to the role of the zygapophysial joint in chronic low back pain. Whereas some have considered this joint to be a significant source of pain [1] [2] [3] [4] [5] [6] others have supported opposite views. [17] [18] [19] [20] [21] Ghormley first advanced the notion that this joint could be the source of a set of symptoms and signs in the low back and coined the term 'facet syndrome',22 and early pathomorphological studies supported this idea. 23 Anatomical studies established that the lumbar zygapophysial joints were richly innervated by nociceptive fibres which provided the anatomical substrate for pain from these [24] [25] [26] [27] joints.
The landmark study by Mooney and Robertson provided important evidence for the existence of zygapophysial joint pain.
I By injecting the zygapophysial joints of normal volunteers under fluoroscopic guidance, they were able to induce both back and referred leg pain; then by injecting the same joints with local anaesthetic, they could abolish the pain. Using similar techniques, a number of authors have been able to abolish pain in 8 A major problem has been the inability to diagnose reliably the pain arising from the zygapophysial joint, using either clinical testsl0 16 17 28 The only reliable method for making a diagnosis of zygapophysial joint pain is the injection of local anaesthetic into the putatively painful joint or around the nerves which innervate it. These diagnostic blocks are based on the precept that if a structure in the low back is the source of pain, anaesthetising that structure should abolish the pain for a period of time commensurate with the duration of action of the local anaesthetic used. If the pain is from a site other than the zygapophysial joint, such a procedure would fail to abolish the pain. One There has been one previous Australian study,9 but neither it nor any other study of lumbar zygapophysial joint pain used placebo controls.
The present study sought to assess the prevalence of pain arising from the lumbar zygapophysial joints and to determine if there are clinical signs that reliably discriminate patients whose pain arises from these joints from patients whose pain arises from some other source. The null hypothesis addressed was that lumbar zygapophysial joint pain is uncommon in an Australian population suffering from low back pain and cannot be predicted clinically using conventional clinical tests.
Patients and methods

PATIENTS
The study population consisted of patients with low back pain referred by rheumatologists at the Royal North Shore Hospital, a major Teaching Hospital in Sydney, between January 1990 and October 1991. The cause of their back pain was not evident from non-invasive diagnostic techniques. Patients were usually referred for the study if they failed to respond to conservative therapy; they were not referred if they were suspected of having anything other than a mechanical cause for their low back pain. Patients were excluded if they were under the age of 18 or over the age of 80 years, if there was a history of previous spinal surgery, if they had a neurological deficit, or if they had a malignancy, spinal infection or inflammatory spinal disorder such as ankylosing spondylitis. Patients included in the study were restricted to categories 1, 2 or 3 in the classification used by the Quebec Task Force for activity related spinal disorders39 as recommended by Deyo.40 None of the patients was receiving 'worker's compensation'. The intention was to study patients with chronic low back pain who had visited a rheumatologist based at a tertiary referral centre. Although such a group represents a small subset of patients in the community with low back pain, these patients are the most difficult to treat and are the most costly to manage.
Seventy one patients were referred, of whom eight failed to proceed: two patients declined to proceed when they were told about the nature of the investigations; two patients were going to leave the country during the investigations and therefore could not proceed; one patient was diagnosed with a carcinoma of the colon and did not commence the study; and three patients experienced too little pain for them to want to proceed with any investigation. Sixty three patients were therefore admitted to the study.
The median age of the population was 59 years (interquartile range 51-0 to 68 0) and the female:male ratio was 3:1. The median duration of low back pain was seven years (interquartile range two to 20) and the median duration of the current episode of low back pain was one year (interquartile range six months to two years). The 4 The physical examination included a variety of measures that might be used in conventional medical practice in the assessment of patients with low back pain: range of lumbar spinal movement between LI and S1, noting movements that induce pain; flexion (measured according to the modified Schober's index, using a spirit goniometer positioned 5 cm above the dimples of Venus, and using the extent of distraction over the distance from the level of the C7 spinous process to the level of the iliac crest); extension measured using a spirit goniometer; lateral flexion (measured as finger to floor distance using an erect rule, and also using a spirit goniometer held against the arm opposite to the side of lateral flexion); sites of spinal and paraspinal tenderness; extent of straight leg raising using a spirit goniometer held against the lower thigh just above the patella; combinations of rotation and extension with the patient standing and assessing whether these manoeuvres are painful; a complete rheumatological and neurological examination. In addition, blood was taken for a full blood count, erythrocyte sedimentation rate and biochemical profile.
A study was performed to assess intraobserver and interobserver agreement for the following tests: modified Schober's index; distraction of C7 to iliac crest distance with forward flexion; forward flexion using a spirit goniometer; extension using a spirit goniometer; lateral flexion to the right and left using finger to floor distance and spirit goniometer; extent of straight leg raising using a spirit goniometer; rotation to the right combined with extension to the left and rotation to the left combined with extension to the right assessing whether pain was induced. The examinations were performed by the principal investigator and a co-investigator (RL) on 10 patients. Each patient was assessed by each examiner at times 0, 15 minutes, and 30 minutes.
INJECTIONS OF ZYGAPOPHYSIAL JOINTS
The criterion standard adopted for the diagnosis of zygapophysial joint pain was the response to local anaesthetic blocks of these joints. The procedure was performed using an image intensifier. Under single blind conditions, patients underwent a placebo injection followed by a series of intra-articular zygapophysial joint injections. The placebo injection was always the first injection; subsequently, on separate occasions, intraarticular injections were performed at L5-S1, L4-5, and L3-4, in that order. The injections were one week apart and the effect of each procedure was assessed for eight hours. Injections were performed sequentially until the patient became pain free or until all three levels had been injected. If a patient obtained less than 50/o relief of pain at one level, that joint was not reinjected but the next joint was injected on the subsequent occasion. When it was suspected that the pain may have arisen from a level higher than L3-4, higher joints were injected; this was the case in three patients. Although patients consented to undergo placebo injections as part of the study, the order of injections was not specified and, therefore, patients were unaware of when they were receiving placebo and active injections. Placebo (9/5% CI 3 to 21 %) of those who completed the study or 11% (95% CI 3 to 19%) of those admitted to the study.
Eighteen patients obtained relief at only one level. Five other patients obtained relief at more than one level after single injections on separate occasions; three had relief at two levels and two at all three levels. When the joints considered as sources of pain were those in which injection gave the greatest relief for each patient, L5-S 1 (eight) and L4-5 (eight) were the most common levels, followed by L3-4 (six) and L2-3 (one).
Assessment of interobserver agreement revealed that measurements of forward flexion were reliable (intraclass correlation coefficients of 0-81-0-94 for the Schober's test and 0-73-0-93 using the inclinometric method), but measurements of extension were variably reliable (0 18-0-83). For lateral flexion, the inclinometric measurements performed slightly better than measurements using the vertical rule. There was greater interobserver agreement for range of lateral flexion than finger to floor distance. Intraclass correlation coefficients ranged from 0-80 to 0-98 for the inclinometric method and from 0 73 to 0-86 when range of movement in centimetres was considered. There was moderate interobserver agreement using the inclinometric method for straight leg raising; intraclass correlation coefficients ranged from 0-63 to 0-86. For rotation combined with extension, kappa scores ranged from 0 35 to 0-80, indicating fair to substantial agreement.48 Intraobserver agreement was best for tests of forward flexion and lateral flexion and least reliable for tests that measured extension.
There was no statistically significant difference in the demographic features, levels of pain and findings on history and physical examination between patients with and without pain originating from the zygapophysial joint (tables [1] [2] [3] [4] . Levels of anxiety and depression were not significantly different Without taking into account the placebo response, the current prevalence of pain of 40% would be falsely increased to 68%; some 32% of patients would falsely be given the diagnosis of zygapophysial joint pain. Failure to consider the placebo response may be one reason why several previous estimates of the prevalence of zygapophysial joint pain were so high. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] The present study addressed the issue of a single zygapophysial joint being the main source of unilateral low back pain or, in the case of bilateral pain, a pair of joints. It expressly did not study the simultaneous contribution of joints from more than one level. It may well be that the prevalence estimate of 40% for zygapophysial joint pain was an underestimate and, had several levels been injected on one occasion, more patients might have been granted the diagnosis. The contribution of multiple joints could form the subject of future studies. Interestingly, five of the 23 patients with a diagnosis of zygapophysial joint pain experienced a greater than 50% diminution in pain after the injection of different joints on separate occasions. No adequate explanation can be provided other than the possibility that these patients obtained placebo responses following some injections but did not experience a placebo response on the day of the saline injection. The majority of the 23 patients (78%) experienced relief at one level only.
The patients included in this study were those seen by rheumatologists practising at a tertiary referral hospital. The prevalence of 40% therefore pertains only to such a population and no inferences can be made as to the wider prevalence of zygapophysial joint pain. These figures are greater than those obtained in a recent study of North American patients with chronic low back pain in which the prevalence of zygapophysial joint pain was 15%. 16 Such discrepancies may be a result of the very different study populations. For example, in the present Australian study, patients were predominantly female, the median age was 59 years and none was receiving worker's compensation. By contrast, in the American study patients were mainly male, the median age was 38 years and 75% were receiving such compensation. '6 One potential criticism of the present study is the problem of referral bias. However, referral bias is not an issue: the present study was designed expressly to study the 
